Terms: = Leukemia AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Treatment
204 results:
1. The RAS-signaling-pathway-mutation-related prognosis in B-cell acute lymphoblastic leukemia: A report from South China children's leukemia group.
Li X; Lin S; Liao N; Mai H; Long X; Liu L; Wu B; Chen Q; Kong Q; Kong X; Liu L; Qin J; Fang J; Zhou D
Hematol Oncol; 2024 May; 42(3):e3265. PubMed ID: 38564328
[TBL] [Abstract] [Full Text] [Related]
2. Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML.
Shimony S; Bewersdorf JP; Shallis RM; Liu Y; Schaefer EJ; Zeidan AM; Goldberg AD; Stein EM; Marcucci G; Lindsley RC; Chen EC; Ramos Perez J; Stein A; DeAngelo DJ; Neuberg DS; Stone RM; Ball B; Stahl M
Leukemia; 2024 Apr; 38(4):762-768. PubMed ID: 38378841
[TBL] [Abstract] [Full Text] [Related]
3. Histiocytic sarcoma following CAR T-cell therapy: a case report.
An K; He Y; Tang Y; Gu X; Qian J; Li B
Int J Hematol; 2024 Mar; 119(3):338-341. PubMed ID: 38294639
[TBL] [Abstract] [Full Text] [Related]
4. [Clinical and molecular biological characterization of patients with accelerated chronic lymphocytic leukemia].
Zhou ZY; Dai LMJ; Sha YQ; Qiu TL; Qin SC; Miao Y; Xia Y; Wu W; Tang HN; Xu W; Li JY; Zhu HY
Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):917-923. PubMed ID: 38185521
[No Abstract] [Full Text] [Related]
5. NLRP3 inflammasome activation and symptom burden in kras-mutated CMML patients is reverted by IL-1 blocking therapy.
Hurtado-Navarro L; Cuenca-Zamora EJ; Zamora L; Bellosillo B; Such E; Soler-Espejo E; Martínez-Banaclocha H; Hernández-Rivas JM; Marco-Ayala J; Martínez-Alarcón L; Linares-Latorre L; García-Ávila S; Amat-Martínez P; González T; Arnan M; Pomares-Marín H; Carreño-Tarragona G; Chen-Liang TH; Herranz MT; García-Palenciano C; Morales ML; Jerez A; Lozano ML; Teruel-Montoya R; Pelegrín P; Ferrer-Marín F
Cell Rep Med; 2023 Dec; 4(12):101329. PubMed ID: 38118408
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax.
Bataller A; Bazinet A; DiNardo CD; Maiti A; Borthakur G; Daver NG; Short NJ; Jabbour EJ; Issa GC; Pemmaraju N; Yilmaz M; Montalban-Bravo G; Takahashi K; Loghavi S; Garcia-Manero G; Ravandi F; Kantarjian HM; Kadia TM
Blood Adv; 2024 Feb; 8(4):927-935. PubMed ID: 38113472
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical Analysis of Infants with Acute Lymphoblastic leukemia (18 cases)].
Li KL; Xiong H; Li H; Wang Z; Chen Z; Yang L; Lu WJ; Qi SS; Sun M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1670-1675. PubMed ID: 38071044
[TBL] [Abstract] [Full Text] [Related]
8. Atypical CML: diagnosis and treatment.
Breccia M
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):476-482. PubMed ID: 38066919
[TBL] [Abstract] [Full Text] [Related]
9. Illuminating (HTLV-1)-induced adult T-cell leukemia/lymphoma transcriptomic signature: A systems virology approach.
Forghani-Ramandi MM; Mostafavi B; Bahavar A; Dehghankar M; Siami Z; Mozhgani SH
Virus Res; 2023 Dec; 338():199237. PubMed ID: 37832654
[TBL] [Abstract] [Full Text] [Related]
10. Targeted single-cell RNA sequencing analysis reveals metabolic reprogramming and the ferroptosis-resistant state in hematologic malignancies.
Shen X; Dong P; Kong J; Sun N; Wang F; Sang L; Xu Y; Zhang M; Chen X; Guo R; Wang S; Lin Q; Jiang Z; Xu S; Zhang C; Bian Z; Wang W; Guo R
Cell Biochem Funct; 2023 Dec; 41(8):1343-1356. PubMed ID: 37823726
[TBL] [Abstract] [Full Text] [Related]
11. DNMT1 expression partially dictates 5-Azacytidine sensitivity and correlates with RAS/MEK/ERK activity in gastric cancer cells.
Chen Z; Zhang L; Yang Y; Liu H; Kang X; Nie Y; Fan D
Epigenetics; 2023 Dec; 18(1):2254976. PubMed ID: 37691391
[TBL] [Abstract] [Full Text] [Related]
12. NRAS
Pan L; Liang F; Chen X; Hao Z; Muyey DM; Chen X; Wang H
Ann Clin Lab Sci; 2023 May; 53(3):389-397. PubMed ID: 37437942
[TBL] [Abstract] [Full Text] [Related]
13. SARS-CoV-2 intrahost evolution in immunocompromised patients in comparison with immunocompetent populations after treatment.
Ahmadi AS; Zadheidar S; Sadeghi K; Nejati A; Salimi V; Hajiabdolbaghi M; Mokhtari-Azad T; Yavarian J
J Med Virol; 2023 Jun; 95(6):e28877. PubMed ID: 37341553
[TBL] [Abstract] [Full Text] [Related]
14. Identification of crucial genes involved in thyroid cancer development.
Kalarani IB; Sivamani G; Veerabathiran R
J Egypt Natl Canc Inst; 2023 May; 35(1):15. PubMed ID: 37211566
[TBL] [Abstract] [Full Text] [Related]
15. MicroRNA-708 emerges as a potential candidate to target undruggable NRAS.
Pang JM; Chien PC; Kao MC; Chiu PY; Chen PX; Hsu YL; Liu C; Liang X; Lin KT
PLoS One; 2023; 18(4):e0284744. PubMed ID: 37083947
[TBL] [Abstract] [Full Text] [Related]
16. Impact of
Mustafa Ali MK; Williams MT; Corley EM; AlKaabba F; Niyongere S
Leuk Lymphoma; 2023 May; 64(5):962-971. PubMed ID: 37042657
[TBL] [Abstract] [Full Text] [Related]
17. [Analysis of 7 cases of pediatric acute myeloid leukemia with DEK-NUP214 fusion gene].
Li XL; Liu LP; Wan Y; Liu F; Chen X; Ren YY; Ruan M; Guo Y; Zhu XF; Yang WY
Zhonghua Er Ke Za Zhi; 2023 Apr; 61(4):357-362. PubMed ID: 37011983
[No Abstract] [Full Text] [Related]
18. Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2).
Richard-Carpentier G; Rausch CR; Sasaki K; Hammond D; Morita K; Takahashi K; Tang G; Kanagal-Shamanna R; Bhalla K; Dinardo CD; Borthakur G; Pemmaraju N; Shpall EJ; Alousi A; Daver NG; Garcia-Manero G; Konopleva MY; Ravandi F; Kantarjian HM; Kadia TM
Haematologica; 2023 Sep; 108(9):2331-2342. PubMed ID: 36951163
[TBL] [Abstract] [Full Text] [Related]
19. Identification of Hub Genes Associated with Resistance to Prednisolone in Acute Lymphoblastic leukemia Based on Weighted Gene Co-expression Network Analysis.
Nekoeian S; Ferdowsian S; Asgari Y; Azizi Z
Mol Biotechnol; 2023 Nov; 65(11):1913-1922. PubMed ID: 36877306
[TBL] [Abstract] [Full Text] [Related]
20. [Clinical Study on the Relationship between Gene Mutation Profile and Prognosis in Pediatric Acute Lymphocyte leukemia].
Chen Y; Qi SS; Ding LL; DU Y; Song N; Wang Z; Yang L; Sun M; Xiong H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):17-24. PubMed ID: 36765471
[TBL] [Abstract] [Full Text] [Related]
[Next]
